Literature DB >> 15202781

Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis.

Harald Mangge1, Holger Hubmann, Stefan Pilz, Konrad Schauenstein, Wilfried Renner, Winfried März.   

Abstract

The development of atherosclerotic lesions encompasses a cascade of cellular and molecular responses that can at best be characterized as an inflammatory process, and exhibits striking similarities to autoimmune diseases, such as rheumatoid arthritis. Chemokines, cytokines and their receptors are critically involved in initiation and perpetuation of atherosclerosis, and they play important roles at all levels in the pathogenesis of this disease. In the present article, the currently available information on cytokines and chemokines as key mediators in atherosclerosis is reviewed. Furthermore, based on recent experiences of our own with very early stages of atherosclerosis, possible new ways to make use of these parameters toward improved early detection, prevention and treatment of this disease are indicated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202781     DOI: 10.1515/CCLM.2004.081

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.

Authors:  Sangeeta Sule; Barbara Fivush; Alicia Neu; Susan Furth
Journal:  Pediatr Nephrol       Date:  2010-10-03       Impact factor: 3.714

2.  OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation.

Authors:  Weiwei Liu; Yanlin Yin; Zihui Zhou; Min He; Yalei Dai
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

3.  Endothelial fibrosis induced by suppressed STAT3 expression mediated by signaling involving the TGF-β1/ALK5/Smad pathway.

Authors:  Alvaro Becerra; Macarena Rojas; Alejandro Vallejos; Vicente Villegas; Lorena Pérez; Claudio Cabello-Verrugio; Felipe Simon
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

4.  Micro-ultrasonographic imaging of atherosclerotic progression and correlation with inflammatory markers in apolipoprotein-E knockout mice.

Authors:  Rong-Juan Li; Ya Yang; Yan-Hong Wang; Jin-Jie Xie; Li Song; Zheng Wang; Yao-Zhong Zhang; Yan-Wen Qin; Zhi-An Li; Xiao-Shan Zhang
Journal:  Tex Heart Inst J       Date:  2011

5.  The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development.

Authors:  Altay Burak Dalan; Bahar Toptaş; Zehra Buğra; Nihat Polat; Hülya Yılmaz-Aydoğan; Arif Çimen; Turgay Isbir
Journal:  Mol Biol Rep       Date:  2013-05-15       Impact factor: 2.316

6.  Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses.

Authors:  Hui Shi; Meiling Liang; Weiyan Chen; Xiuting Sun; Xiang Wang; Chenghsun Li; Yiying Yang; Zhisheng Yang; Wutao Zeng
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

7.  Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis.

Authors:  Dong Ju Son; Yu Yeon Jung; Young Sik Seo; Heonyong Park; Dong Hun Lee; Sanghyeon Kim; Yoon-Seok Roh; Sang Bae Han; Do Young Yoon; Jin Tae Hong
Journal:  Theranostics       Date:  2017-06-01       Impact factor: 11.556

Review 8.  Beyond Macrophages and T Cells: B Cells and Immunoglobulins Determine the Fate of the Atherosclerotic Plaque.

Authors:  Harald Mangge; Florian Prüller; Wolfgang Schnedl; Wilfried Renner; Gunter Almer
Journal:  Int J Mol Sci       Date:  2020-06-08       Impact factor: 5.923

Review 9.  Immunological outcomes of exercise in older adults.

Authors:  David S Senchina; Marian L Kohut
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 10.  Cytokines and atherosclerosis: a comprehensive review of studies in mice.

Authors:  Robert Kleemann; Susanne Zadelaar; Teake Kooistra
Journal:  Cardiovasc Res       Date:  2008-05-16       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.